Clinical Trials Logo

Filter by:
NCT ID: NCT06119035 Completed - PreDiabetes Clinical Trials

Insulin Modelling Based on Plasma Glucose Measures Via a Minimally-Invasive Glucose Sensor

Start date: November 6, 2023
Phase: N/A
Study type: Interventional

The study aims to evaluate insulin as a potential biomarker for prediabetes in Singapore Chinese subjects.

NCT ID: NCT06033872 Completed - Diabetes Mellitus Clinical Trials

Effectiveness of Education, Medication Adjustment and Telemonitoring in Reducing Diabetes Complications During Ramadan

Start date: January 25, 2021
Phase: N/A
Study type: Interventional

Introduction Diabetes is a global emergency with detrimental clinical and financial consequences. Poorly managed diabetes leads to a myriad of serious complications, especially cardiovascular and infectious complications, with consequent increased cost and mortality rate. For Muslims in particular, the annual fasting month of Ramadan is one such period when diabetes control is essential. Adequate adjustments in diabetes management need to be made in line with the allowed meal times to avoid the risk of diabetes complications during Ramadan. Objective Investigators aim to investigate the effectiveness of focused diabetes education and medication adjustment with telemonitoring to reduce diabetes complications during Ramadan fasting as well as to assess the cost-effectiveness of this intervention for Muslims with diabetes in Singapore. Methodology In a parallel group randomized controlled trial, investigators aim to recruit 100 adults with diabetes who are able to fast at least 15 days in Ramadan. Participants will be randomized to the intervention group comprising of focused diabetes education, medication adjustment and telemonitoring, and control group receiving standard care. Participants will be followed up during Ramadan. The primary outcome is the incidence of hypoglycemia in Ramadan. The secondary outcomes are (i) incidence of other diabetes complications in Ramadan episodes including hyperglycemia, episodes of acute infections, attendances in clinic and emergency department and that of hospital admission, and (ii) cost-effectiveness of the intervention. Clinical Significance The study enables investigators to evaluate focused pre-Ramadan diabetes education and medication adjustment with tele-monitoring as a means to reduce the markedly increased risk of diabetes complications for a large population during the fasting month, with potential for increased cost-effectiveness through reducing unscheduled attendances at clinic and hospital.

NCT ID: NCT06030271 Completed - Clinical trials for Chronic Total Occlusion (CTO)

A Prospective, Non-Randomized Pivotal Clinical Investigation to Demonstrate the Safety and Performance of the TrueCross Single-Use Microcatheter

Start date: October 13, 2022
Phase: N/A
Study type: Interventional

The trial is a pivotal clinical investigation, which is a prospective, non-randomized pivotal clinical investigation to demonstrate the safety and performance of the TrueCross Single-use Microcatheter.

NCT ID: NCT06022835 Completed - Clinical trials for End Stage Renal Disease on Dialysis

Chlorhexidine Gluconate-gel Dressing for Exit Site Infection in Peritoneal Dialysis

Start date: September 27, 2019
Phase: N/A
Study type: Interventional

Exit site infection (ESI) is one of the major predisposing factors to peritoneal dialysis (PD) related peritonitis. Chlorhexidine Gluconate (CHG) has been widely used for cutaneous disinfection for half a century. TegadermTM CHG is a water-proof dressing with gel pads that provide 2% CHG to the skin surface and effectively prevents catheter-related infections for intravascular catheters. However, its use has not been accessed in patients with PD catheters. We aim to evaluate the effectiveness of TegadermTM CHG dressing in preventing ESI in PD patients.

NCT ID: NCT05961852 Completed - Clinical trials for Arteriovenous Fistula Stenosis

COmbiNing Cutting and Drug-Eluting Balloon for Resistant Arteriovenous Fistula sTenOsis (CONCERTO)

CONCERTO
Start date: August 15, 2018
Phase: Phase 1
Study type: Interventional

To evaluate the preliminary efficacy of combination of cutting and drug-coated balloon for the treatment of resistant AVF stenosis.

NCT ID: NCT05953441 Completed - Sepsis Clinical Trials

Artificial Intelligence Versus Human-controlled Doctor in Virtual Reality Simulation for Sepsis Team Training

Start date: August 8, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to compare the effectiveness of Artificial Intelligence virtual doctor with human-controlled virtual doctor avatars on nursing students' sepsis care and interprofessional communication.

NCT ID: NCT05945589 Completed - Quality of Life Clinical Trials

The Singapore Art-Health Study

Start date: March 2, 2021
Phase: N/A
Study type: Interventional

The goal of the Singapore Art-Health RCT is to examine the effect of a standardized 12-week museum -based participatory art program on health condition, well-being, and quality of life in older community dweller, one that adheres to the Montreal Art-Health framework with culturally specific modifications that are fitting to the local Singaporean context. Participants will be randomized into an intervention group of a passive control group. Participants in the intervention group will be invited to participate in the 12-week Singapore Art-Health Intervention held at the National Gallery Singapore. All participants will be invited to complete four online psychometric assessments. Participants in the intervention group will be invited to completed an additional post-intervention survey and a feasibility focus group.

NCT ID: NCT05932446 Completed - Healthy Clinical Trials

A Study to Compare Two Formulations of LY3819469 in Healthy Participants

Start date: June 30, 2023
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to assess two formulations of LY3819469 based on the amount that gets into the blood stream and how long it takes the body to get rid of it, when given to healthy participants. The information about any adverse effects experienced will be collected and the tolerability of LY3819469 will also be evaluated. Screening is required within 28 days prior to the enrolment. For each participant, the total duration of the clinical trial will be about 17 weeks including screening and follow-up periods.

NCT ID: NCT05914688 Completed - Healthy Clinical Trials

A Study to Compare Two Formulations of LY3209590 in Healthy Participants

Start date: June 26, 2023
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to compare the two formulations of LY3209590 in healthy participants. Study participants will be administered each formulation at separate study visits. Blood samples will be taken to compare how the body handles study drugs. The information about any adverse effects experienced will be collected and the tolerability of LY3209590 will also be evaluated. Screening is required within 28 days prior to enrolment. For each participant, the total duration of the clinical trial will be about 184 days including screening.

NCT ID: NCT05908968 Completed - Clinical trials for Foot Ulcer, Diabetic

Assessing the Effects of ELO Water on Diabetic Foot Ulcers

Start date: September 19, 2017
Phase: N/A
Study type: Interventional

This pilot study examined the effects of ELO water, a commercially-available oxygen-enriched drinking water, on wound healing in patients with diabetic foot ulcers over 12 weeks.